| PERIOD ENDING | 2-Oct-09 | 3-Jul-09 | 3-Apr-09 | 2-Jan-09 | | Total Revenue | 228,146 | 191,213 | 172,990 | 210,228 | | Cost of Revenue | 135,618 | 114,263 | 108,115 | 126,361 | | | Gross Profit | 92,528 | 76,950 | 64,875 | 83,867 | | | Operating Expenses | | Research Development | 31,090 | 29,666 | 28,596 | 34,644 | | Selling General and Administrative | 26,311 | 24,215 | 22,794 | 27,101 | | Non Recurring |
-
|
-
| 15,982 |
-
| | Others | 2,175 | 1,548 | 1,246 | 1,149 | | | | Total Operating Expenses |
-
|
-
| 68,618 |
-
| | | | Operating Income or Loss | 32,952 | 21,521 | (3,743) | 20,973 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (5,705) | (32) | (13) | 3,437 | | Earnings Before Interest And Taxes | 27,247 | 21,489 | (3,756) | 24,410 | | Interest Expense | 807 | 890 | 808 | 1,139 | | Income Before Tax | 26,440 | 20,599 | (4,564) | 23,271 | | Income Tax Expense | (29,565) | 750 | 25 | 1,247 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 51,939 | 19,849 | (4,589) | 22,024 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 56,005 | 19,849 | (4,589) | 22,024 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $56,005 | $19,849 | ($4,589) | $22,024 |
|
0.10% Nasdaq 
0.27%
Income Statement
